Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
Zymeworks authorized a new $125 million share repurchase program for 2026, replacing its terminated 2025 program. The previous program saw the company buy back approximately 4.2 million shares for $102.3 million at an average price of $24.36.
Key figures
- Outstanding shares
- 73000000
- Prior repurchases value
- 102300000
- Prior avg purchase price
- 24.36
- Prior repurchases shares
- 4197553
- Repurchase authorization
- 125000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.